Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Sep 2025 is 5.81% vs 4.77% in Sep 2024
Standalone Net Profit
Growth in half year ended Sep 2025 is -31.55% vs 53.98% in Sep 2024
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Sep 2025 is -47.09% vs -22.64% in Sep 2024
Interest
Growth in half year ended Sep 2025 is 0.63% vs 0.63% in Sep 2024
Operating Profit Margin (Excl OI)
Growth in half year ended Sep 2025 has fallen from Sep 2024
Compare Half Yearly Results Of TTK Healthcare With
Figures in Cr
Standalone Half Yearly Results
Change(INR)
Change(%)
Net Sales
430.00
1,305.43
-875.43
-67.06%
Other Operating Income
0.00
0.00
0.00
Total Operating income
430.00
1,305.43
-875.43
-67.06%
Raw Material Cost
97.62
843.16
-745.54
-88.42%
Purchase of Finished goods
95.80
14.60
81.20
556.16%
(Increase) / Decrease In Stocks
6.25
-1.55
7.80
503.23%
Employee Cost
82.44
136.58
-54.14
-39.64%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
139.88
165.06
-25.18
-15.26%
Total Expenditure (Excl Depreciation)
421.99
1,157.85
-735.86
-63.55%
Operating Profit (PBDIT) excl Other Income
8.01
147.58
-139.57
-94.57%
Other Income
36.95
27.33
9.62
35.20%
Operating Profit (PBDIT)
44.96
174.91
-129.95
-74.30%
Interest
1.61
9.70
-8.09
-83.40%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
43.35
165.21
-121.86
-73.76%
Depreciation
4.40
24.33
-19.93
-81.92%
Profit Before Tax
38.95
140.88
-101.93
-72.35%
Tax
5.56
36.46
-30.90
-84.75%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
33.39
104.41
-71.02
-68.02%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
33.39
104.41
-71.02
-68.02%
Equity Capital
14.13
171.00
-156.87
-91.74%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
23.63
6.11
17.52
286.74%
Diluted Earnings per share
23.63
6.11
17.52
286.74%
Operating Profit Margin (Excl OI)
1.86%
11.31%
0.00
-9.45%
Gross Profit Margin
10.08%
12.66%
0.00
-2.58%
PAT Margin
7.77%
8.00%
0.00
-0.23%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 430.00 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 5.81% vs 4.77% in Sep 2024
Half Yearly - Standalone Net Profit
Standalone Net Profit 33.39 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is -31.55% vs 53.98% in Sep 2024
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 8.01 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is -47.09% vs -22.64% in Sep 2024
Half Yearly - Interest
Interest 1.61 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 0.63% vs 0.63% in Sep 2024
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 1.86%
in Sep 2025Figures in %
Growth in half year ended Sep 2025 has fallen from Sep 2024






